Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
new york blog main
10
×
san francisco blog main
biotech
boston blog main
boston top stories
national top stories
new york top stories
san francisco top stories
detroit blog main
raleigh-durham blog main
san diego blog main
seattle blog main
texas blog main
wisconsin blog main
boulder/denver blog main
detroit top stories
indiana blog main
national
raleigh-durham top stories
san diego top stories
seattle top stories
texas top stories
wisconsin top stories
boulder/denver top stories
cancer
clinical trials
fda
indiana top stories
deals
ipo
medical devices
startups
cancer immunotherapy
investing
merck
pfizer
renaissance capital
celgene
What
life
10
×
science
companies
week
ipo
bio
roundup
biotechs
new
street
wall
biotech
capital
firms
haul
ipos
little
millions
momentum
moves
public
raised
sciences
therapeutics
way
welcomed
admits
ago
arena’s
arrival
bails
becker
better
big
billions
black
boost
boston’s
bounty
brand
Language
unset
Current search:
life
×
" new york blog main "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
In Boston’s Shadow, Rhode Island Fights for Life Science Jobs, Respect
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M